{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:28:04Z","timestamp":1790051284240,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"scientific research of the Heilongjiang Provincial Health Commission","award":["20220404050660"],"award-info":[{"award-number":["20220404050660"]}]},{"name":"scientific research of the Heilongjiang Provincial Health Commission","award":["20210404050337"],"award-info":[{"award-number":["20210404050337"]}]},{"name":"scientific research of the Heilongjiang Provincial Health Commission","award":["20220404050752"],"award-info":[{"award-number":["20220404050752"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77638-6","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T11:08:39Z","timestamp":1730286519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["AI predictive modeling of survival outcomes for renal cancer patients undergoing targeted therapy"],"prefix":"10.1038","volume":"14","author":[{"given":"Yaoqi","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jirui","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"issue":"2","key":"77638_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/oncolo\/oyab056","volume":"27","author":"S Gulati","year":"2022","unstructured":"Gulati, S., Labaki, C., Karachaliou, G. S., Choueiri, T. K. & Zhang, T. First-line treatments for metastatic clear cell renal cell carcinoma: An ever-enlarging Landscape. Oncologist. 27 (2), 125\u2013134 (2022).","journal-title":"Oncologist"},{"issue":"1","key":"77638_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.euo.2021.08.003","volume":"5","author":"D Benamran","year":"2022","unstructured":"Benamran, D. et al. Treatment options for de novo metastatic clear-cell renal cell carcinoma: current recommendations and future insights. Eur. Urol. Oncol. 5 (1), 125\u2013133 (2022).","journal-title":"Eur. Urol. Oncol."},{"issue":"1","key":"77638_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74 (1), 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"77638_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74 (3), 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"19","key":"77638_CR5","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1056\/NEJMoa1510665","volume":"373","author":"RJ Motzer","year":"2015","unstructured":"Motzer, R. J. et al. Nivolumab versus everolimus in advanced renal-cell carcinoma. N Engl. J. Med. 373 (19), 1803\u20131813 (2015).","journal-title":"N Engl. J. Med."},{"key":"77638_CR6","doi-asserted-by":"publisher","first-page":"e2200407","DOI":"10.1200\/PO.22.00407","volume":"7","author":"JJ Boyle","year":"2023","unstructured":"Boyle, J. J., Pfail, J. L., Lichtbroun, B. J. & Singer, E. A. Adjuvant therapy for renal cell carcinoma: End points, outcomes, and risk assessments. JCO Precis Oncol. 7, e2200407 (2023).","journal-title":"JCO Precis Oncol."},{"key":"77638_CR7","doi-asserted-by":"publisher","first-page":"100929","DOI":"10.1016\/j.drup.2023.100929","volume":"67","author":"J Jin","year":"2023","unstructured":"Jin, J. et al. Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers. Drug Resist. Updat. 67, 100929 (2023).","journal-title":"Drug Resist. Updat"},{"issue":"2","key":"77638_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.eururo.2022.10.004","volume":"83","author":"Z Bakouny","year":"2023","unstructured":"Bakouny, Z. et al. Upfront cytoreductive nephrectomy for metastatic renal cell carcinoma treated with immune checkpoint inhibitors or targeted therapy: An observational study from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur. Urol. 83 (2), 145\u2013151 (2023).","journal-title":"Eur. Urol."},{"issue":"2","key":"77638_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s40291-021-00568-w","volume":"26","author":"Y Dong","year":"2022","unstructured":"Dong, Y., Xu, J., Sun, B., Wang, J. & Wang, Z. MET-targeted therapies and clinical outcomes: A systematic literature review. Mol. Diagn. Ther. 26 (2), 203\u2013227 (2022).","journal-title":"Mol. Diagn. Ther."},{"issue":"1","key":"77638_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13046-019-1259-z","volume":"38","author":"A Rotte","year":"2019","unstructured":"Rotte, A. Combination of CTLA-4 and PD-1 blockers for treatment of cancer. J. Exp. Clin. Cancer Res. 38 (1), 255 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"77638_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ucl.2015.08.009","volume":"43","author":"AG Winer","year":"2016","unstructured":"Winer, A. G., Motzer, R. J. & Hakimi, A. A. Prognostic biomarkers for response to vascular endothelial growth factor-targeted therapy for renal cell carcinoma. Urol. Clin. North. Am. 43 (1), 95\u2013104 (2016).","journal-title":"Urol. Clin. North. Am."},{"issue":"10","key":"77638_CR12","doi-asserted-by":"publisher","first-page":"101213","DOI":"10.1016\/j.xcrm.2023.101213","volume":"4","author":"Z Guan","year":"2023","unstructured":"Guan, Z. et al. Artificial intelligence in diabetes management: Advancements, opportunities, and challenges. Cell. Rep. Med. 4 (10), 101213 (2023).","journal-title":"Cell. Rep. Med."},{"key":"77638_CR13","doi-asserted-by":"publisher","first-page":"946915","DOI":"10.3389\/fendo.2022.946915","volume":"13","author":"X Huang","year":"2022","unstructured":"Huang, X. et al. Artificial intelligence promotes the diagnosis and screening of diabetic retinopathy. Front. Endocrinol. (Lausanne). 13, 946915 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"11","key":"77638_CR14","doi-asserted-by":"publisher","first-page":"7998","DOI":"10.1007\/s00330-022-08784-6","volume":"32","author":"BS Kelly","year":"2022","unstructured":"Kelly, B. S. et al. Radiology artificial intelligence: A systematic review and evaluation of methods (RAISE). Eur. Radiol. 32 (11), 7998\u20138007 (2022).","journal-title":"Eur. Radiol."},{"issue":"8","key":"77638_CR15","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cels.2021.06.006","volume":"12","author":"M Mann","year":"2021","unstructured":"Mann, M., Kumar, C., Zeng, W. F. & Strauss, M. T. Artificial intelligence for proteomics and biomarker discovery. Cell. Syst. 12 (8), 759\u2013770 (2021).","journal-title":"Cell. Syst."},{"issue":"10","key":"77638_CR16","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s11427-018-9342-2","volume":"61","author":"F Zhong","year":"2018","unstructured":"Zhong, F. et al. Artificial intelligence in drug design. Sci. China Life Sci. 61 (10), 1191\u20131204 (2018).","journal-title":"Sci. China Life Sci."},{"key":"77638_CR17","doi-asserted-by":"publisher","first-page":"1021684","DOI":"10.3389\/fonc.2023.1021684","volume":"13","author":"E Barkan","year":"2023","unstructured":"Barkan, E. et al. Artificial intelligence-based prediction of overall survival in metastatic renal cell carcinoma. Front. Oncol. 13, 1021684 (2023).","journal-title":"Front. Oncol."},{"issue":"5","key":"77638_CR18","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41416-021-01640-2","volume":"126","author":"S Chen","year":"2022","unstructured":"Chen, S. et al. Machine learning-based pathomics signature could act as a novel prognostic marker for patients with clear cell renal cell carcinoma. Br. J. Cancer. 126 (5), 771\u2013777 (2022).","journal-title":"Br. J. Cancer"},{"issue":"1","key":"77638_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ucl.2023.06.002","volume":"51","author":"JE Knudsen","year":"2024","unstructured":"Knudsen, J. E., Rich, J. M. & Ma, R. Artificial intelligence in pathomics and genomics of renal cell carcinoma. Urol. Clin. North. Am. 51 (1), 47\u201362 (2024).","journal-title":"Urol. Clin. North. Am."},{"issue":"1","key":"77638_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.annonc.2023.10.125","volume":"35","author":"A Prelaj","year":"2024","unstructured":"Prelaj, A. et al. Artificial intelligence for predictive biomarker discovery in immuno-oncology: A systematic review. Ann. Oncol. 35 (1), 29\u201365 (2024).","journal-title":"Ann. Oncol."},{"issue":"1","key":"77638_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ucl.2023.06.007","volume":"51","author":"AG Raman","year":"2024","unstructured":"Raman, A. G., Fisher, D., Yap, F., Oberai, A. & Duddalwar, V. A. Radiomics and artificial intelligence: Renal cell carcinoma. Urol. Clin. North. Am. 51 (1), 35\u201345 (2024).","journal-title":"Urol. Clin. North. Am."},{"issue":"12","key":"77638_CR22","doi-asserted-by":"publisher","first-page":"8858","DOI":"10.1007\/s00330-023-09869-6","volume":"33","author":"P Nie","year":"2023","unstructured":"Nie, P. et al. A CT-based deep learning radiomics nomogram outperforms the existing prognostic models for outcome prediction in clear cell renal cell carcinoma: A multicenter study. Eur. Radiol. 33 (12), 8858\u20138868 (2023).","journal-title":"Eur. Radiol."},{"issue":"4","key":"77638_CR23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.euf.2021.04.024","volume":"7","author":"KS Rallis","year":"2021","unstructured":"Rallis, K. S. et al. Radiomics for renal cell carcinoma: Predicting outcomes from immunotherapy and targeted therapies-a narrative review. Eur. Urol. Focus. 7 (4), 717\u2013721 (2021).","journal-title":"Eur. Urol. Focus"},{"key":"77638_CR24","unstructured":"Akin, O. et al., J. The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma Collection (TCGA-KIRC) Version 3 ed 2016."},{"issue":"6","key":"77638_CR25","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s10278-013-9622-7","volume":"26","author":"K Clark","year":"2013","unstructured":"Clark, K. et al. The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository. J. Digit. Imaging. 26 (6), 1045\u20131057 (2013).","journal-title":"J. Digit. Imaging"},{"issue":"9","key":"77638_CR26","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","volume":"30","author":"A Fedorov","year":"2012","unstructured":"Fedorov, A. et al. 3D slicer as an image computing platform for the quantitative imaging network. Magn. Reson. Imaging. 30 (9), 1323\u20131341 (2012).","journal-title":"Magn. Reson. Imaging"},{"issue":"3","key":"77638_CR27","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cmpb.2014.02.014","volume":"114","author":"B Kurt","year":"2014","unstructured":"Kurt, B., Nabiyev, V. V. & Turhan, K. A novel automatic suspicious mass regions identification using Havrda & Charvat entropy and Otsu\u2019s N thresholding. Comput. Methods Programs Biomed. 114 (3), 349\u2013360 (2014).","journal-title":"Comput. Methods Programs Biomed."},{"key":"77638_CR28","doi-asserted-by":"crossref","unstructured":"Xiao, T., Liu, Y., Zhou, B., Jiang, Y. & Sun, J. Unified perceptual parsing for scene understanding. ArXiv ; (2018). abs\/1807.10221.","DOI":"10.1007\/978-3-030-01228-1_26"},{"issue":"5","key":"77638_CR29","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3748\/wjg.v29.i5.879","volume":"29","author":"Y Chu","year":"2023","unstructured":"Chu, Y. et al. Convolutional neural network-based segmentation network applied to image recognition of angiodysplasias lesion under capsule endoscopy. World J. Gastroenterol. 29 (5), 879\u2013889 (2023).","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"77638_CR30","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/SLA.0000000000004594","volume":"276","author":"A Madani","year":"2022","unstructured":"Madani, A. et al. Artificial intelligence for intraoperative guidance: using semantic segmentation to identify surgical anatomy during laparoscopic cholecystectomy. Ann. Surg. 276 (2), 363\u2013369 (2022).","journal-title":"Ann. Surg."},{"issue":"1","key":"77638_CR31","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1186\/s12903-023-03362-8","volume":"23","author":"S Vinayahalingam","year":"2023","unstructured":"Vinayahalingam, S. et al. Intra-oral scan segmentation using deep learning. BMC Oral Health. 23 (1), 643 (2023).","journal-title":"BMC Oral Health"},{"key":"77638_CR32","doi-asserted-by":"publisher","first-page":"105075","DOI":"10.1016\/j.ebiom.2024.105075","volume":"102","author":"O Lang","year":"2024","unstructured":"Lang, O. et al. Using generative AI to investigate medical imagery models and datasets. EBioMedicine. 102, 105075 (2024).","journal-title":"EBioMedicine"},{"issue":"8","key":"77638_CR33","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s11604-022-01270-5","volume":"40","author":"Y Ohno","year":"2022","unstructured":"Ohno, Y. et al. Newly developed artificial intelligence algorithm for COVID-19 pneumonia: utility of quantitative CT texture analysis for prediction of favipiravir treatment effect. Jpn J. Radiol. 40 (8), 800\u2013813 (2022).","journal-title":"Jpn J. Radiol."},{"issue":"11","key":"77638_CR34","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.diii.2021.06.005","volume":"102","author":"N Lassau","year":"2021","unstructured":"Lassau, N. et al. Three artificial intelligence data challenges based on CT and ultrasound. Diagn. Interv Imaging. 102 (11), 669\u2013674 (2021).","journal-title":"Diagn. Interv Imaging"},{"issue":"12","key":"77638_CR35","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1007\/s00259-023-06339-5","volume":"50","author":"C Sachpekidis","year":"2023","unstructured":"Sachpekidis, C. et al. Application of an artificial intelligence-based tool in [(18)F]FDG PET\/CT for the assessment of bone marrow involvement in multiple myeloma. Eur. J. Nucl. Med. Mol. Imaging. 50 (12), 3697\u20133708 (2023).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"2","key":"77638_CR36","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s10278-022-00732-6","volume":"36","author":"M Salehi","year":"2023","unstructured":"Salehi, M. et al. Deep learning-based non-rigid image registration for high-dose rate brachytherapy in inter-fraction cervical cancer. J. Digit. Imaging. 36 (2), 574\u2013587 (2023).","journal-title":"J. Digit. Imaging"},{"key":"77638_CR37","doi-asserted-by":"crossref","unstructured":"Grosso, A. A. et al. 3D virtual model for robot-assisted partial nephrectomy in highly-complex cases (PADUA \u2a7e 10). Urologia :3915603241252905. (2024).","DOI":"10.1177\/03915603241252905"},{"issue":"1","key":"77638_CR38","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s00345-024-05043-9","volume":"42","author":"AA Grosso","year":"2024","unstructured":"Grosso, A. A. et al. Three-dimensional virtual model for robot-assisted partial nephrectomy: A propensity-score matching analysis with a contemporary control group. World J. Urol. 42 (1), 338 (2024).","journal-title":"World J. Urol."},{"issue":"6","key":"77638_CR39","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1590\/s1677-5538.ibju.2020.1075","volume":"47","author":"AA Grosso","year":"2021","unstructured":"Grosso, A. A. et al. Robot-assisted partial nephrectomy with 3D preoperative surgical planning: Video presentation of the florentine experience. Int. Braz J. Urol. 47 (6), 1272\u20131273 (2021).","journal-title":"Int. Braz J. Urol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77638-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77638-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77638-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T11:12:55Z","timestamp":1730286775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77638-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77638"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77638-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4558621\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"assertion":[{"value":"10 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was reviewed and approved by the ethics board of the Heilongjiang Provincial Hospital. Due to the open datasets, the requirement for signed informed consent from the participants or their guardians was acquired by the TCGA Renal Phenotype Research Group. The requirement of informed consent for studying the open datasets is waived by the ethics board of the Heilongjiang Provincial Hospital.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and participant consent"}}],"article-number":"26156"}}